Obesity and Metabolic Disorders: It can regulate adipose tissue metabolism, improve insulin sensitivity and lipid profiles, and enhance glucose metabolism, so it may prove useful in the treatment of metabolic dysfunction
Disproportionality analysis from world health organization data on semaglutide, liraglutide, and suicidality[J]
Providers increasingly encounter patients who have already started treatment before establishing care or without a traditional prescription pathway
#HealthcareInnovation #ObesityCare #ChronicDisease #Pharma #GLP1 #PublicHealth #IndiaHealthcare #HealthEquity #LifeSciences #FutureOfMedicine News source credits: LIVEMINT ( To view or add a comment, sign in 270 followers
Paul Hetrick, PharmD Published: Mar 27, 2025 Key takeaway: If Wegovy is too expensive, unavailable, or not the right fit, several strong alternatives exist including tirzepatide (Zepbound), oral semaglutide, and non-GLP-1 medications